Resolution of Inflammation in Retinal Disorders: Briefly the State

Resolution of Inflammation in Retinal Disorders: Briefly the State

The most frequent retinal diseases, such as diabetic retinopathy, age-related macular degeneration and posterior uveitis, are underlined by oxidative stress or aging-induced retinal inflammation, which contributes to vision impairing or loss. Resolution of inflammation is emerging as a critical phas...

Full description

Bibliographic Details
Main Authors:	Maria Consiglia Trotta, Carlo Gesualdo, Francesco Petrillo, Caterina Claudia Lepre, Alberto Della Corte, Giancuomo Cavasso, Giulia Maggiore, Anca Hermenean, Francesca Simonelli, Michele D’Amico, Settimio Rossi
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Series:	International Journal of Molecular Sciences
Subjects:	retinopathy inflammation pro-resolving mediators lipoxins resolvins protectins
Online Access:	https://www.mdpi.com/1422-0067/23/9/4501

Similar Items

Specialized Pro-Resolving Mediators in Neuroinflammation: Overview of Studies and Perspectives of Clinical Applications
by: Mariarosaria Valente, et al.
Published: (2022-07-01)

Pro-resolving lipid mediators (SPMs) and their actions in regulating miRNA in novel resolution circuits in inflammation
by: Charles N Serhan, et al.
Published: (2012-10-01)

Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection
by: Anandita Pal, et al.
Published: (2020-08-01)

Omega fatty acids and resolution of inflammation: A new twist in an old tale
by: Mittal Antush, et al.
Published: (2010-01-01)

Resolution of Inflammation after Skeletal Muscle Ischemia–Reperfusion Injury: A Focus on the Lipid Mediators Lipoxins, Resolvins, Protectins and Maresins
by: Cindy Barnig, et al.
Published: (2022-06-01)

Utility of the Specialized Pro-Resolving Mediators as Diagnostic and Prognostic Biomarkers in Disease
by: Jesmond Dalli, et al.
Published: (2022-02-01)

Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?
by: Undurti N. Das, et al.
Published: (2017-08-01)

Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid
by: María Paz Beyer, et al.
Published: (2023-07-01)

Are EPA and DHA Derivatives Involved in IBD Remission?
by: Justyna Kikut, et al.
Published: (2022-04-01)

The Role of Resolvins, Protectins and Marensins in Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Dominika Maciejewska-Markiewicz, et al.
Published: (2021-06-01)

Resolvins, Protectins, and Maresins: DHA-Derived Specialized Pro-Resolving Mediators, Biosynthetic Pathways, Synthetic Approaches, and Their Role in Inflammation
by: Inês Ferreira, et al.
Published: (2022-03-01)

Métabolisme oxygéné des acides gras polyinsaturés et fonction dans les cellules sanguines et vasculaires1
by: Lagarde Michel
Published: (2011-03-01)

Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation[S]
by: Anne Barden, et al.
Published: (2014-11-01)

Resolution of inflammation: Therapeutic potential of pro-resolving lipids in Type 2 diabetes mellitus and associated renal complications
by: Emma eBorgeson, et al.
Published: (2012-10-01)

Formyl peptide receptor 1 suppresses gastric cancer angiogenesis and growth by exploiting inflammation resolution pathways
by: Nella Prevete, et al.
Published: (2017-04-01)

Specialized Pro-resolving Lipid Mediators: Modulation of Diabetes-Associated Cardio-, Reno-, and Retino-Vascular Complications
by: Monica de Gaetano, et al.
Published: (2018-12-01)

Infection, Inflammation, and Immunity in Sepsis
by: Undurti N. Das
Published: (2023-08-01)

The GPR40 Agonist GW9508 Enhances Neutrophil Function to Aid Bacterial Clearance During E. coli Infections
by: Patricia R. Souza, et al.
Published: (2020-09-01)

Host Lipid Mediators in Leprosy: The Hypothesized Contributions to Pathogenesis
by: Carlos A. M. Silva, et al.
Published: (2018-02-01)

Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?
by: Nils Helge Schebb, et al.
Published: (2022-03-01)

Omega 3 Fatty Acid and Skin Diseases
by: Yu Sawada, et al.
Published: (2021-02-01)

The Anti-Inflammatory Role of Omega-3 Polyunsaturated Fatty Acids Metabolites in Pre-Clinical Models of Psychiatric, Neurodegenerative, and Neurological Disorders
by: Juliette Giacobbe, et al.
Published: (2020-02-01)

Changes in Circulating Acylated Ghrelin and Neutrophil Elastase in Diabetic Retinopathy
by: Maria Consiglia Trotta, et al.
Published: (2024-01-01)

Therapeutic Effects of Specialized Pro-Resolving Lipids Mediators on Cardiac Fibrosis via NRF2 Activation
by: Gyeoung Jin Kang, et al.
Published: (2020-12-01)

Role of Specialized Pro-Resolving Mediators in Modifying Host Defense and Decreasing Bacterial Virulence
by: Julianne M. Thornton, et al.
Published: (2021-11-01)

Immunomodulation of periodontitis with SPMs
by: Vaibhav Sahni, et al.
Published: (2023-10-01)

Inflammatory and Pro-resolving Lipids in Trypanosomatid Infections: A Key to Understanding Parasite Control
by: Rodrigo A. López-Muñoz, et al.
Published: (2018-08-01)

Simulated Microgravity Affects Pro-Resolving Properties of Primary Human Monocytes
by: Alessandro Leuti, et al.
Published: (2024-01-01)

Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases
by: Jun Miyata, et al.
Published: (2015-01-01)

Bioactive lipid-based therapeutic approach to COVID-19 and other similar infections
by: Undurti N. Das
Published: (2021-04-01)

The Protectin Family of Specialized Pro-resolving Mediators: Potent Immunoresolvents Enabling Innovative Approaches to Target Obesity and Diabetes
by: Trond Vidar Hansen, et al.
Published: (2019-01-01)

Effects of the Calix[4]arene Derivative Compound OTX008 on High Glucose-Stimulated ARPE-19 Cells: Focus on Galectin-1/TGF-β/EMT Pathway
by: Maria Consiglia Trotta, et al.
Published: (2022-07-01)

Comparison of effectiveness of low-dose aspirin versus omega-3 fatty acids as adjuvants to nonsurgical periodontal therapy in Type II diabetic patients with chronic periodontitis
by: Prathyusha Rampally, et al.
Published: (2019-01-01)

Randomized, double-blind, placebo-controlled study to evaluate the effect of treatment with an SPMs-enriched oil on chronic pain and inflammation, functionality, and quality of life in patients with symptomatic knee osteoarthritis: GAUDI study
by: Ingrid Möller, et al.
Published: (2023-06-01)

Inhibition of Galectins and the P2X7 Purinergic Receptor as a Therapeutic Approach in the Neurovascular Inflammation of Diabetic Retinopathy
by: Caterina Claudia Lepre, et al.
Published: (2023-06-01)

Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation
by: Antonio Recchiuti, et al.
Published: (2020-09-01)

RvD1<sub>n-3 DPA</sub> Downregulates the Transcription of Pro-Inflammatory Genes in Oral Epithelial Cells and Reverses Nuclear Translocation of Transcription Factor p65 after TNF-α Stimulation
by: Maria G. Balta, et al.
Published: (2022-11-01)

Early evidence of efficacy for orally administered SPM-enriched marine lipid fraction on quality of life and pain in a sample of adults with chronic pain
by: Nini Callan, et al.
Published: (2020-10-01)

Corrigendum: Resolvin D1 Modulates the Intracellular VEGF-Related miRNAs of Retinal Photoreceptors Challenged With High Glucose
by: Rosa Maisto, et al.
Published: (2020-06-01)

The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still’s disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles
by: Luca Navarini, et al.
Published: (2023-04-01)